Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

129
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
129
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

114
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
114
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

204
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
204
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

154
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
154
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.2K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.2K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

230
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
230

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scan-wise generalized PET denoising with contrastive adversarial learning.

Physics in medicine and biology·2026
Same author

Imaging Traumatic Brain Injuries in Mice with Potassium Channel PET Tracer [<sup>18</sup>F]3F4AP.

Journal of neurotrauma·2026
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

DUAL PROMPTING FOR DIVERSE COUNT-LEVEL PET DENOISING.

Proceedings. IEEE International Symposium on Biomedical Imaging·2025
Same author

First evaluation in multiple sclerosis using PET tracer [<sup>18</sup>F]3F4AP demonstrates heterogeneous binding across lesions.

European journal of nuclear medicine and molecular imaging·2025
Same author

Imaging Demyelinated Axons After Spinal Cord Injuries with PET Tracer [<sup>18</sup>F]3F4AP.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025

Related Experiment Video

Updated: Sep 15, 2025

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
14:21

Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking

Published on: August 6, 2013

18.4K

Bayesian Posterior Distribution Estimation of Kinetic Parameters in Dynamic Brain PET Using Generative Deep Learning

Yanis Djebra, Xiaofeng Liu, Thibault Marin

    IEEE Transactions on Medical Imaging
    |July 15, 2025
    PubMed
    Summary

    This study introduces an improved deep learning model (iDDPM) for faster and more accurate analysis of Positron Emission Tomography (PET) scans. The new method significantly reduces computation time while precisely estimating kinetic parameters for neurodegenerative disease research.

    More Related Videos

    Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
    09:03

    Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

    Published on: October 22, 2019

    10.3K
    Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level
    07:28

    Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level

    Published on: January 24, 2025

    479

    Related Experiment Videos

    Last Updated: Sep 15, 2025

    Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking
    14:21

    Creating Dynamic Images of Short-lived Dopamine Fluctuations with lp-ntPET: Dopamine Movies of Cigarette Smoking

    Published on: August 6, 2013

    18.4K
    Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET
    09:03

    Radiotracer Administration for High Temporal Resolution Positron Emission Tomography of the Human Brain: Application to FDG-fPET

    Published on: October 22, 2019

    10.3K
    Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level
    07:28

    Studying Metabolic Brain Connectivity Using 2-Deoxy-2-[18F]Fluoro-D-Glucose Dynamic Positron Emission Tomography at the Single-subject Level

    Published on: January 24, 2025

    479

    Area of Science:

    • Neuroimaging
    • Medical Physics
    • Computational Biology

    Background:

    • Positron Emission Tomography (PET) enables molecular imaging of processes like hyperphosphorylated tau (p-tau) in neurodegenerative diseases.
    • Tracer kinetic modeling quantifies p-tau density and cerebral perfusion from dynamic PET data.
    • Image noise introduces uncertainty in kinetic parameters, necessitating robust estimation methods like Bayesian inference.

    Purpose of the Study:

    • To develop a computationally efficient deep learning method for estimating kinetic parameter posterior distributions in dynamic PET imaging.
    • To leverage an Improved Denoising Diffusion Probabilistic Model (iDDPM) for enhanced accuracy and speed compared to existing techniques.

    Main Methods:

    • Proposed an iDDPM-based approach for estimating kinetic parameter posterior distributions in dynamic PET.
    • Evaluated the method on a [18F]MK6240 study, comparing it against Conditional Variational Autoencoder with dual decoder (CVAE-DD) and Wasserstein GAN with gradient penalty (WGAN-GP).
    • Utilized Metropolis-Hasting Markov Chain Monte Carlo (MCMC) for reference posterior distribution inference.

    Main Results:

    • The iDDPM-based method demonstrated superior performance over CVAE-DD and WGAN-GP.
    • Achieved significant computational speedup (over 230x faster) compared to MCMC methods.
    • Inferred accurate kinetic parameter posterior distributions with low mean error (< 0.67%) and high precision (standard deviation error < 7.23%).

    Conclusions:

    • The proposed iDDPM method offers a computationally efficient and accurate alternative for kinetic parameter estimation in dynamic PET.
    • This advancement holds promise for improving the analysis of neurodegenerative diseases like Alzheimer's using PET imaging.
    • Deep learning models can effectively address noise challenges in PET imaging, enhancing diagnostic capabilities.